Emergent Biosolutions Inc (EBS): Next-Year EPS Estimate 180.00%
As of 2026-06-04, Emergent Biosolutions Inc (EBS) has a next-year EPS growth estimate of 180.00%.
Analyst estimates for EBS have remained steady in the most recent observable window, with next-year EPS growth projected at 180.00%. Current-year growth stands at -78.76%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 180.00%
- EPS growth this year
- -78.76%
- EPS next quarter (est)
- -$0.09
- Last price
- $8.44
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 180.00% | -78.76% | -$0.09 | $8.44 |
| 2026-06-03 | 180.00% | -78.76% | -$0.09 | $7.93 |
| 2026-06-02 | 180.00% | -78.76% | -$0.09 | $8.21 |
| 2026-06-01 | 180.00% | -78.76% | -$0.09 | $8.49 |
| 2026-05-31 | 180.00% | -78.76% | -$0.09 | $9.12 |
| 2026-05-28 | 180.00% | -78.76% | -$0.09 | $9.18 |
| 2026-05-27 | 180.00% | -78.76% | -$0.09 | $9.00 |
| 2026-05-26 | 180.00% | -78.76% | -$0.09 | $9.13 |
| 2026-05-25 | 180.00% | -78.76% | -$0.09 | $8.45 |
| 2026-05-24 | 180.00% | -78.76% | -$0.09 | $8.45 |
| 2026-05-21 | 180.00% | -78.76% | -$0.09 | $8.37 |
| 2026-05-20 | 180.00% | -78.76% | -$0.09 | $8.15 |
| 2026-05-19 | 180.00% | -78.76% | -$0.09 | $8.06 |
| 2026-05-18 | 180.00% | -78.76% | -$0.09 | $8.13 |
| 2026-05-17 | 180.00% | -78.76% | -$0.09 | $7.94 |
| 2026-05-14 | 180.00% | -78.76% | -$0.09 | $8.21 |
| 2026-05-13 | 180.00% | -78.76% | -$0.09 | $8.45 |
| 2026-05-12 | 180.00% | -78.76% | -$0.09 | $8.50 |
| 2026-05-11 | 180.00% | -78.76% | -$0.09 | $8.95 |
| 2026-05-10 | 180.00% | -78.76% | -$0.09 | $9.50 |
| 2026-05-07 | 180.00% | -78.76% | -$0.09 | $9.13 |
| 2026-05-06 | 180.00% | -78.76% | -$0.09 | $9.10 |
| 2026-05-05 | 180.00% | -78.76% | -$0.09 | $9.05 |
| 2026-05-04 | 180.00% | -78.76% | -$0.09 | $8.54 |
Recent News
- Emergent BioSolutions Inc. Q1 2026 Earnings Call SummaryMoby
- Emergent BioSolutions Inc (EBS) Q1 2026 Earnings Call Highlights: Strong Revenue and Strategic ...GuruFocus.com
- Emergent Biosolutions: Q1 Earnings SnapshotAssociated Press
- Emergent BioSolutions Reports First Quarter 2026 Financial ResultsGlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Emergent Biosolutions Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Emergent Biosolutions Inc (EBS) has a next-year EPS growth estimate of 180.00%, based on analyst consensus.
What sector and industry does Emergent Biosolutions Inc belong to?▾
Emergent Biosolutions Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. EBS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Emergent Biosolutions Inc (EBS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports